2.46
price down icon1.20%   -0.03
 
loading

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-30 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
93.90%
0.9391
0.4843 1.0198 0.1039 0.8973
Operating Income/Loss
16.16%
-1.9037
-1.6389 -1.8987 -1.0044 -1.9324
Nonoperating Income/Loss
213.33%
0.1543
0.0492 0.2814 0.0423 0.2642
Income/Loss From Continuing Operations Before Tax
10.05%
-1.7495
-1.5896 -1.6173 -0.9621 -1.6682
Income Tax Expense/Benefit
100.00%
-
0.0008 - - -
Income/Loss From Continuing Operations After Tax
10.00%
-1.7495
-1.5904 -1.6173 -0.9621 -1.6682
Net Income/Loss
10.00%
-1.7495
-1.5904 -1.6173 -0.9621 -1.6682
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
32.36%
7.0227
5.3058 -0.9911 0.0168 3.2218
Basic Earnings Per Share
16.67%
-0.25
-0.30 -0.44 -0.29 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$84.54
price up icon 0.86%
$22.91
price up icon 7.03%
$32.47
price up icon 2.06%
$102.71
price up icon 0.62%
$166.10
price up icon 2.22%
biotechnology ONC
$331.09
price up icon 3.45%
Kapitalisierung:     |  Volumen (24h):